Literature DB >> 16712870

First report of two Taiwanese siblings with sialidosis type I: a 10-year follow-up study.

Chiung-Mei Chen1, Szu-Chia Lai, I-Cheng Chen, Kai-Cheng Hsu, Rong-Kuo Lyu, Long-Sun Ro, Hong-Shiu Chang.   

Abstract

We report the clinical features, electrophysiological findings and genetic characteristics of the first two Taiwanese siblings ever reported with sialidosis type I. We also provide a 10-year follow-up result. Enzymological analysis revealed a primary sialidase deficit. The back-averaged electroencephalography demonstrated myoclonic jerk-related cortical activities and the somatosensory evoked potential studies revealed giant cortical components. During the 10-year follow-up, the brain magnetic resonance images of the younger brother remained normal, whereas they showed mild cerebellar atrophy in the older sister. Macular cherry red spots were absent in both siblings. However, visual evoked potential revealed progressively prolonged latencies of P100 bilaterally, which was consistent with progressive deterioration of the siblings' visions. DNA analysis showed that the siblings had a homozygous missense point mutation c.544A-->G (Ser182Gly) in the exon 3 of the alpha-N-acetyl-neuraminidase (NEU1) gene. The mutation is predicted to cause a decreased sialidase activity but the mutant sialidase can still be targeted to the lysosomes, which may correlate with the mild clinical phenotypes and absent cherry red spots in the siblings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16712870     DOI: 10.1016/j.jns.2006.03.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Clinical and genetic characteristics of type I sialidosis patients in mainland China.

Authors:  Rui-Juan Lv; Tao-Ran Li; Yu-Di Zhang; Xiao-Qiu Shao; Qun Wang; Li-Ri Jin
Journal:  Ann Clin Transl Neurol       Date:  2020-05-29       Impact factor: 4.511

2.  Sialidosis type I: ophthalmological findings.

Authors:  Isa Sobral; Maria da Luz Cachulo; João Figueira; Rufino Silva
Journal:  BMJ Case Rep       Date:  2014-10-16

Review 3.  NEU1-A Unique Therapeutic Target for Alzheimer's Disease.

Authors:  Aiza Khan; Consolato M Sergi
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.